Related Experiment Video
Updated: Mar 8, 2026

06:28
E-Patient Counseling Trial E-PACO: Computer Based Education versus Nurse Counseling for Patients to Prepare for Colonoscopy
Published on: August 1, 2019
9.3K
Predicting the effectiveness of the Finnish population-based colorectal cancer screening programme
Sherry Yueh-Hsia Chiu1,2, Nea Malila3,4, Amy Ming-Fang Yen5
11 Department of Health Care Management, Chang Gung University, Tao-Yuan, Taiwan.
Journal of Medical Screening
|January 14, 2017
Summary
A new model predicts colorectal cancer (CRC) screening effectiveness. The Finnish CRC screening program model showed a 9% reduction in CRC mortality and a 14% decrease in advanced CRC.
Area of Science:
- Oncology
- Public Health
- Biostatistics
Background:
- Colorectal cancer (CRC) screening effectiveness evaluation requires long-term follow-up due to its long natural history.
- A temporal multi-state natural history model offers an alternative for predicting CRC screening effectiveness.
Purpose of the Study:
- To demonstrate the utility of a temporal multi-state natural history model for predicting CRC screening effectiveness.
- To estimate the impact of CRC screening on mortality and advanced CRC reduction.
Main Methods:
- Utilized a Markov model to analyze data from the Finnish population-based biennial CRC screening program (2004-2007).
- Estimated pre-clinical incidence, mean sojourn time (MST), and faecal occult blood test (FOBT) sensitivity.
- Simulated the effects of five screening rounds on advanced CRC and mortality reduction in a cohort of 500,000 individuals aged 60-69.
Main Results:
- Mean sojourn times (MST) for localized and non-localized CRC were 2.06 and 1.36 years, respectively.
- FOBT sensitivity estimates were 65.12% for localized and 73.70% for non-localized CRC.
- Predicted relative risk reduction for non-localized CRC and CRC death was 0.86 and 0.91, respectively, in the screened group.
Conclusions:
- The developed model predicted a 9% reduction in CRC mortality.
- The model also predicted a 14% reduction in advanced CRC based on preliminary Finnish screening program results.

